About SBRI
SBRI is a venture capital firm founded in 2007. It is primarily based out of United Kingdom. As of Jun 2024, SBRI has invested in 5 companies. It primarily invests in Grant (prize money) round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Healthcare. Most recently it participated in the $***** Grant (prize money) round of NovocommsKey Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Grant (prize money) & Seed
SBRI's List of All Investments
SBRI has a portfolio of 5 companies. Their most notable investmentis in Inovus MedicalTheir portfolio spans across and United Kingdom. They have invested in Life Sciences, High Tech, Healthcare, across Grant (prize money), Seed stages. Here is the list of all investments by SBRI:
Key facts about Inovus Medical
- Founded Year: 2012
- Location: St Helens (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $9.71M
- Employee Count: 38 as on Aug 31, 2026
- Investors: Norgine Ventures, Mercia Ventures and 4 Others
- Latest Funding Round: Series A, May 20, 2022, $*****
2. NovaBiotics
Developer of therapeutics for infectious diseases. The pipeline antimicrobial peptides that are engineered to target bacteria and fungi with AMR‑agnostic action which includes Novamycin, Novarifyn, and Luminaderm for fungal and bacterial infections. It offers Cysteamine Aminothiol Platform which offers Lynovex for cystic fibrosis and Nylexa is an antibiotic potentiator for covid.
Key facts about NovaBiotics
- Founded Year: 2009
- Location: United Kingdom
- Annual Revenue: £0 - £1M as on Nov 30, 2021
- Stage: Early Stage
- Total Funding till date: $13M
- Employee Count: 15 as on Aug 31, 2026
- Investors: Woodford Investment Management, Aurora Capital Group and 3 Others
- Latest Funding Round: Grant (prize money), Feb 18, 2019, $*****
3. iosBio
IosBiopharma develops therapeutic solutions for treating diseases like Covid-19, Influenza & others. It is a research-based company that provides the OraPro-COVID-19 a coronavirus vaccine that delivers double immunity via a capsule. The vaccine provides non-replicating viral vectors to the gastrointestinal tract to elicit effective immunity against infectious diseases. It has also developed a multi-strain influenza vaccine, Butyrylcholinesterase for the treatment of neurological damage tissues, and others. The platform uses THERM-SB patented technology for the thermo-stabilization of viruses, vaccines, and proteins.THERM-SB is a formulation of simple sugars and non-toxic small molecules in discrete concentrations that enables the vaccine to be stored in liquid or lyophilized state.
Key facts about iosBio
- Founded Year: 2002
- Location: Burgess Hill (United Kingdom)
- Stage: Series C
- Total Funding till date: $7.81M
- Employee Count: 12 as on Aug 31, 2026
- Investors: Shackleton Ventures, RAB Capital and 67 Others
- Latest Funding Round: Grant (prize money), Feb 23, 2022, $*****
4. Novocomms
Provider of wireless communication systems, antenna design, and turnkey solutions. It delivers antenna components for various wireless technologies and provides systems integration for private 5G and industrial IoT. The company offers solutions for sectors including telecommunications, consumer electronics, space, smart cities, healthcare, industrial IoT, academia, agriculture, and military. It provides services from concept design to large volume production.
Key facts about Novocomms
- Founded Year: 2019
- Location: Birmingham (United Kingdom)
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $2.88M
- Employee Count: 24 as on Aug 31, 2026
- Investors: SBRI
- Latest Funding Round: Grant (prize money), Jun 14, 2024, $*****
MicroBioSensors develops point-of-care diagnostic devices for detecting microbial infections. Its platform technology detects microbial infections and shows it with an all-or-nothing color change. Applications include use in detecting infections in patients that require long-term use of medical devices, such as peritoneal dialysis, urinary catheters and wound care.
Key facts about Microbiosensor
- Founded Year: 2013
- Location: Keswick (United Kingdom)
- Stage: Seed
- Total Funding till date: $1.83M
- Employee Count: 2 as on Sep 30, 2026
- Investors: Maven Capital Partners, Mrc and 21 Others
- Latest Funding Round: Seed, Nov 14, 2018, $*****
SBRI's Year-on-Year Investment Trends
SBRI has invested in 5 companies over the last 12 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Novocomms and most recent follow-on round was in Microbiosensor.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 |
2019 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
SBRI's Investments by Stage
SBRI has made 4 investments in Grant (prize money) stage with an average round size of $2.39M and 1 investment in Seed stage with an average round size of $190K.Stage of entry | No. of Investments |
|---|---|
Grant (prize money) | 4 |
Seed | 1 |
Note: We have considered here, only first round of investments
SBRI's Investments by Sector
SBRI has a diverse portfolio, with companies operating in the Life Sciences, Sustainability Tech, Healthcare and High Tech. Notably, it has invested in 5 Enterprise (B2B) companies and 4 Tech companies.Sector | No. of Investments |
|---|---|
Life Sciences | 3 |
Sustainability Tech | 3 |
Healthcare | 1 |
High Tech | 1 |
Note: We have considered here, only first round of investments
SBRI's Investments by Geography
SBRI has made most investments in United Kingdom (5).SBRI's recent investments
SBRI has not made any investment in 2026 so far.Here are the most recent investments by SBRI:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 14, 2024 | United Kingdom | Grant (prize money) | 8665 | - | |
Feb 18, 2019 | United Kingdom | Grant (prize money) | 5231 | - | |
Jul 26, 2018 | United Kingdom | Seed | 8373 | - | |
Mar 08, 2017 | United Kingdom | Grant (prize money) | 7417 | - | |
Mar 21, 2015 | United Kingdom | Grant (prize money) | 8113 | - |
Co-investors of SBRI
Over the past 12 years, 12 investors have co-invested in SBRI's portfolio companies. This includes funds and angels.
- Invested before SBRI: Northern Powerhouse Investment Fund, Woodford Investment Management and 3 others have invested in rounds before SBRI. There is 1 company where Northern Powerhouse Investment Fund has invested before SBRI and 1 company where Woodford Investment Management has invested before SBRI.
- Invested after SBRI: A total of 7 investors have invested in SBRI's portfolio after their investments. Top Investors include EIT Health (1 company), SBRI Healthcare (1 company) and Norgine Ventures (1 company).
Recent News related to SBRI
•
Global medical business launched in a bedroom secures more than £140,000 for expansionLiverpool Business News•Jul 28, 2018•Inovus, Inovus Medical, SBRI
